1. Monaghan P, Van der Wall H, Mackey DWJ, et al: Modified Technegas in the assessment of pulmonary epithelial permeability. Aust NZ J Med 20:476, 1990.
2. Monaghan P, Murray IPC, Mackey DWJ et al. An improved radionuclide Technique for the Detection of Altered Pulmonary Permeability. J Nucl Med 32:1945-1949, 1991.
3. Bellen JC, Penglis S, Tsopelas CL. Radiochemical analysis of modified Technegas. ANZ Soc Nucl Med Proceedings, Perth W. Australia, May, 1991.*
4. Ashburn WL, Belezzuoli EV, Dillon WA, et al: Technetium -99m labelled micro aerosol ("Pertechnegas") - new agent for ventilation imaging in suspected pulmonary embolism. Clin Nucl Med 18: 1045-1052, 1993.
5. Bellen JC, Penglis S, Tsopelas L: Radiochemical Characterisation of Modified Technegas. Nucl Med and Biol 20:(5), 715-717, 1993.
6. Scalzetti EM, Grossman ZD, Gagne GM: Experimentally produced pulmonary arterial occlusion in the dog: identification with Pertechnegas inhalation. Radiology 186: (2), 423-426, 1993.
7. Ball D, Sephton R, Irving L, Crennan E: Radiation pneumonitis: generalised lung changes detected by radionuclide imaging following focal lung irradiation. Australas Radiol 36: (2) 142-143, 1992.
8. Sephton RG, Irving L, Ball D, et al. Measurement of alveolar-capillary in the early detection of Radiation Pneumonitis.
9. Belezzuoli EV, Ashburn WL, Hoogland D, Perez VL and Yeung DW. Ventilation Imaging in suspected pulmonary emboli: A comparison of Technetium-99m Pertechnegas with Xenon-133. (Refer to 50). J Nucl Med 35:48p, 1994.*
10. Carril JM, Banzo JJ, Quirce R, et al. Pertechnegas and ^99m Tc - DTPA aerosol ventilation studies in AIDS with opportunistic lung infection. Nucl Med Commun 15: 240, 1994.
11. Shimada T, Kawakami K, Moriya E, Mori Y. Chemical Characteristics and Clinical Significance of Pertechnegas. J Nucl Med 35:48P, 1994*.
12. James JM, Herman KJ, Lloyd JJ, et al. Initial Experience with Pertechnegas. Eur J Nucl Med 21:(10) - suppl:S87, 1994.*
13. Carill JM, Banzo I, Quirce R, et al. Pertechnegas-Tc-99m and DTPA-Tc-99m Aerosols in the Lung Infections of HIV (+) Patients. Eur J Nucl Med 21:(10) - suppl;S88, 1994.*
14. Mackey DWJ, Dasaklis CE, Fisher KJ, et al. Fourier Transform Mass Spectrometry of Technegas and Pertechnegas. Eur J Nucl Med 21:(10) - suppl;S87, 1994.*
15. Isawa T, Teshima T, Anazawa Y, et al. Does Pertechnegas really help assessing pulmonary epithelial pereability and imaging lungs? Eur J Nucl Med 21:(10) - suppl;S240, 1994.*
16. Scalzetti EM, Gagne GM. The Transition from Technegas to Pertechnegas. J Nucl Med 36:268-269,1995.
17. Lloyd JJ, Shields RA, Taylor CJ, et al. Technegas & Pertechnegas particle size distribution. Eur J. Nucl Med 22:(5);473-476, 1995.
18. Kotzerke J, Strumpf A, Scäfers H*, et al. Decreased Alveolar Permeability after heart-tx. J Nucl Med 36:5P, 1995.
19. Smith R, Artz SA, Kelly DM, Krepshaw JD, Hoogland D. Tc-99m Pertechnegas ventilation imaging: abnormal washout clearance patterns in patients with suspected Pulmonary Embolism. J Nucl Med 36:250P, 1995.
20. James JM, Lloyd JJ, Herman KJ, Leahy BC, Shields RA, Testa HJ. Pertechnegas lung clearance studies: A new method for study of pulmonary function. Eur J. Nucl Med 21 (8) 741, 1994.*
21. Kotzerke J, Strumpf A, Schäfers H-J, Hundeshagen H. Alveolar permeability after heart-TX. Eur J. Nucl Med 21 (8) 742, 1994.*
22. Fanti S, Marengo M, Pancaldi D, et al. Evaluation of Pulmonary Clearance of Pertechnegas (modified Technegas). Eur J. Nucl Med 21 (8) 837, 1994.*
23. Banzo I, Quirce R, Jiménez-Bonilla J, et al. Contribution of Pertechnegas and DTPA aerosol studies in pneumocystis carinii pneumonia. Eur J. Nucl Med 21 (8) 838, 1994.*
24. Wiseman GA, Mullan BP. Preliminary results comparing ¹³³Xe and ⁹⁹Tc^m-pertechnegas ventilation imaging. Nucl Med Commun 16:243,1995.*
25. Kotzerke J, Strumpf A, Emter M, et al. Pertechnegas Clearance: A Compartment Model. Eur J Nucl Med 22:731;1995*.
26. Fanti S, Compagnone G, Pancaldi D, et al. Evaluation of lung clearance of inhaled Pertechnegas. Ann Nucl Med 10: 1, 147-151, 1996.
27. Isawa T, Teshima T, Anazawa Y, Miki M, Mahmud AM. Inhalation of Pertechnegas: similar clearance from the lungs to that of inhaled pertechnetate aerosol. Nucl Med Commun 16: 741-746, 1995
28. Mackey DWJ, Jackson PJ, Baker RJ, et al. Pertechnegas: physical properties and utility as a ventilation agent. J Nucl Med 38: 163-167, 1997.
29. Sato J, Takashio T, Shuke N, et al. Evaluation of regional lung clearance with Pertechnegas lung dynamic SPECT. Ann Nucl Med 10 : (suppl), S130, 1996*.
30. Kotzerke J, Van Der Hoff J, Burchett W, et al. A compartmental model for alveolar clearance of Pertechnegas. J. Nucl Med 37:(12) 2066 - 2071, 1966.
31. Burch WM, Browitt RJ. The Transition from Technegas to Pertechnegas (letter in response to ref. # 16 ) J Nucl Med 37 (11), 1917-1918, 1996.
32. Isawa T, Lee B-T, Hiraga K. High-resolution electron microscopy of Technegas and Pertechnegas. Nucl Med Commun 17: 147-152; 1996.
33. Lloyd JJ, Lawson RS, Shields RA. High-resolution electron microscopy of Technegas and Pertechnegas (letter + reply) Nucl Med Commun 17: 822-823; 1996.
34. Sato J, Takashio T, Shuke Y, et al. different acute and chronic effects of smoking on the lung permeability: evaluation with Pertechnegas dynamic SPECT. J Nucl Med 37: (5 suppl), 5P; 1996*.
35. Kawakami K, Topics of pulmonary nuclear medicine, Annal Nucl Med. 11, 2 1997.
36. Kotzerke J, Rodegro-Heinsen R, Wagner TOF, Haverich A. Alveolar permeability after lung transplantation &emdash; Pertechnegas detects easily inflammation and rejection. Eur J Nucl Med 25: (8); 1096, 1998*
37. Mouratidis B, Nogrady S, Horowitz M, et al. Increased Pertechnegas lung clearance in interstitial lung disease. Clin Nucl Med 24: (2), 105-108; 1999